Parker Waichman

Speaker Bio

Melanie H. Muhlstock joined Parker Waichman as an Associate in 2005 and is now Managing Partner, Mass Torts Department. Ms. Muhlstock has a Bachelor of Arts degree from the University of Wisconsin at Madison and a Juris Doctorate from Loyola University – Chicago School of Law. She is in good standing and licensed to practice law in the State and Federal Courts of New York and New Jersey and the United States Supreme Court. Ms. Muhlstock has been recognized by The National Trial Lawyers as one of the Top 100 Trial Lawyers in 2014, 2015, 2016, 2017, 2018, 2019, and 2020.

During her tenure at Parker Waichman, Ms. Muhlstock has specifically focused her personal injury practice on the representation of plaintiffs in complex and serious litigation including multidistrict litigation and class action matters that involve pharmaceuticals, medical devices, and other consumer products and complex matters. In that capacity, she has facilitated the resolution of numerous serious injury and other claims.

Over the last fourteen years, Ms. Muhlstock has often been selected to serve on discovery and expert sub-committees for Plaintiffs’ Steering Committees nationwide. Notably, she was personally appointed as Chair of the Non-Party Discovery Committee of the Plaintiffs’ Steering Committee for In re Actos (Pioglitazone) Products Liability Litigation (MDL No. 2299) and Co-Chair of the Non-Party Discovery Sub-Committee of the Plaintiffs’ Steering Committee for In Re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100). She was also trial counsel in the matter of Maria Stone, et al. v. Ethicon Incorporated, et al., Docket Number: 2:12-cv-00274-ROS, U.S. District Court, District of Arizona, a product liability case involving transvaginal mesh, which was tried before the Honorable Roslyn O. Silver in the Summer of 2017.

Her experience also includes membership on various discovery, science and law and briefing sub-committees of the Plaintiffs’ Steering Committees in In Re: Denture Cream Products Liability Litigation (MDL No. 2051); In re: Bayer Corp. Combination Aspirin Products Marketing and Sales Practices Litigation (MDL No. 2023); In Re: Ortho Evra Products Liability Litigation (MDL No. 1742); In Re: Guidant Corp. Implantable Defibrillators Products Liability Litigation (MDL No. 1708); as well as the New York Coordinated Proceeding involving the contact lens solution, ReNu with MoistureLoc. Ms. Muhlstock has further worked with her colleagues at Parker Waichman as well as the other members of the Plaintiffs’ Steering Committee in In re Mirena IUD Products Liability Litigation (MDL No. 2434), the New Jersey Mirena IUD Multicounty Litigation, and In re: Davol/C.R. Bard Hernia Mesh Multi-Case Management (Master Docket No. PC-2018-999, Superior Court, State of Rhode Island) to further the litigation for the common benefit of all plaintiffs.

Moreover, with more than twenty (20) years’ experience in this field, Ms. Muhlstock is a frequently invited to speak on mass tort litigation at national seminars attended by members of the Bar and Bench. These seminars include Harris Martin, Masters of Mass Torts, Mass Torts Made Perfect, Mass Tort Nexus, and the Louisiana State Bar Association Conference.

Prior to joining Parker Waichman, Ms. Muhlstock represented pharmaceutical companies and manufacturers of medical devices and consumer products. During that time, she co-authored “Liability for Off-Label Uses: Coordinating a Response with the Prescribing Physician”, which was presented at the American Conference Institute’s Drug and Medical Device Litigation Conference in December, 1998. While in law school, she was also an extern for the United States Attorney’s Office in the Northern District of Illinois where she tried petty offense cases and assisted in the prosecution of organized crime and narcotics felony cases.